EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Effect of ephedrine and theophylline on weight loss, resting energy expenditure and lipoprotein lipase activity in obese over-fed rats


International Journal of Obesity and Related Metabolic Disorders 17(6): 343-347
Effect of ephedrine and theophylline on weight loss, resting energy expenditure and lipoprotein lipase activity in obese over-fed rats
The effect of ephedrine (E) and theophylline (T), administered alone and in combination (E/T), on weight loss, resting energy expenditure and post-heparin lipoprotein lipase activity in plasma (PHLA) and in adipose tissue (ATLP) were investigated in obese over-fed rats, who had been diet restricted (-40% of normal caloric intake) for three weeks. E, T and E/T significantly increased weight loss in all experimental groups as compared to the controls. Weight loss was achieved not only by preventing the adaptive fall in resting energy expenditure associated with diet restriction, but by raising it above basal level. The effect of E/T mixture was no greater than that of E or T alone. E, T and E/T administration increased PHLA in plasma while hypocaloric diet alone did not influence the activity of the enzyme. ATLP in the epididymal fat pads decreased insignificantly in all experimental groups, as well as in the controls. Serum cholesterol levels were not influenced by hypocaloric diet and by drug administration, but serum triglycerides increased significantly in E, T and E/T treated groups. The elevation of PHLA after ephedrine and/or theophylline administration was mostly due to an increase in the hepatic lipase (HL) level. This enzyme contributes to the removal of the atherogenic intermediate density lipoproteins from blood serum. The increased HL activity in drug-treated, diet-restricted obese rats may therefore play a role in the prevention of atherosclerosis.


Accession: 002355417

PMID: 8392500



Related references

Effect of ephedrine and theophylline on weight loss, resting energy expenditure and lipoportein lipase activity in obese over-fed rats. International journal of obesity and related metabolic disorders: journal of the International Association for the Study of Obesity 17(6): 343-347, 1993

Effect of ephedrine and theophylline on weight loss in obese overfed rats. International Journal of Obesity 17(SUPPL 1): S82, 1993

Effect of weight loss on resting energy expenditure in obese prepubertal children. International Journal of Obesity and Related Metabolic Disorders 16(1): 41-47, 1992

Effect of weight loss on resting energy expenditure in hypertensive obese women. Diabetologia 40(SUPPL 1): A265, 1997

Effect of weight loss on resting energy expenditure in hypertensive and normotensive obese women. Clinical and Experimental Hypertension 20(4): 403-416, 1998

The effect of alpha-linolenic acid on resting energy expenditure following weight loss in obese humans. Medicine & Science in Sports & Exercise 35(5 Supplement): S248, May, 2003

Effects of weight loss, ephedrine and aspirin on energy expenditure in obese women. International Journal of Obesity and Related Metabolic Disorders 17 Suppl 1: S45-S48, 1993

Postheparin lipoprotein lipase activity in obese children treated with hypocaloric diet supplemented with ephedrine of theophylline. International Journal of Obesity 17(SUPPL 1): S80, 1993

Effects of weight loss and weight maintenance on the serum lipids, lipoprotein lipase and hepatic triglyceride lipase activities in obese rats. International Journal of Obesity 13(3): 279-288, 1989

Changes in body composition and resting energy expenditure after rapid weight loss: is there an energy-metabolism adaptation in obese patients?. International Journal of Obesity and Related Metabolic Disorders 19(2): 119-125, 1995